China Ginsenoside Ra3 90985-77-6, Find details about China Ginseng P. E, Ginsenoside RO from China Ginsenoside Ra3 90985-77-6
Alias : (3beta,12beta)-12-hydroxy-20-((o-beta-d-xylopyranosyl-(1→3)-o-beta-d-glucopyranosyl-(1→6)-beta-d-glucopyranosyl)oxy)dammar-24-en-3-yl 2-o-beta-d-glucopyranosyl-beta-d-glucopyranoside
Ginsenoside Ra3 is extracted from roots and rhizomes of Panax ginseng, shows potent antioxidant biological activity.
Weight | Price | Stock |
---|---|---|
5mg | 586.80$ | In Stock |
10mg | 1120.80$ | In Stock |
20mg | 2170.80$ | In Stock |
50mg | 4741.80$ | In Stock |
>200mg | Get quote | In Stock |
How to purchase?
IC50 Value & Target:
In Vitro: Plasma 20(S)-protopanaxadiol and 20(S)-protopanaxatriol could be used as pharmacokinetic markers to reflect the subject's microbial activities, as well as the timely-changes and interindividual differences in plasma levels of their respective oxidized metabolites. [2].
In Vivo: After ingestion of Sanchi extract, ginsenosides Ra3, Rb1, Rd, Rg1, F1, Rh1, and notoginsenoside R1 were measured in plasma samples. Deglycosylated metabolites Compound-K, protopanaxadiol, and protopanaxatriol were also detected in plasma. Notably, several metabolites of protopanaxadiol and protopanaxatriol were found in human plasma and characterized, the plasma concentrations of which were significantly higher than those of the circulating ginsenosides. Conclusion: Although the ginsenoside aglycones protopanaxadiol and protopanaxatriol were not contained in the test Sanqi extract, their oxidized metabolites represented a class of major circulating compounds after ingestion of the herbal extract to humans. [1]. The PK profiles of the Sanqi ginsenosides in humans were comparable to those found in rats. Slight interspecies differences could have been due to humans being relatively poor biliary excretors compared with rats.[3].
M.Wt | 1241.41 |
---|---|
Formula | C59H100O27 |
CAS No. | 90985-77-6 |
Solvent & Solubility | 10 mM in DMSO |
Storage | 2-8ºC & Sealed storage |
Alias : (3beta,12beta)-12-hydroxy-20-((o-beta-d-xylopyranosyl-(1→2)-o-alpha-l-arabinofuranosyl-(1→6)-beta-d-glucopyranosyl)oxy)dammar-24-en-3-yl 2-o-beta-d-glucopyranosyl-beta-d-glucopyranoside
Ginsenoside Ra2 is extracted from roots and rhizomes of Panax ginseng.
Weight | Price | Stock |
---|---|---|
10mg | 326.20$ | In Stock |
20mg | 618.80$ | In Stock |
50mg | 1418.20$ | In Stock |
100mg | 2538.20$ | In Stock |
>300mg | Get quote | In Stock |
Leave message How to purchase?
IC50 Value & Target:
In Vitro: Have no relevant experimental datas.
In Vivo: Have no relevant experimental datas.
M.Wt | 1211.38 |
---|---|
Formula | C58H98O26 |
CAS No. | 83459-42-1 |
Solvent & Solubility | 10 mM in DMSO |
Storage | 2-8ºC & Sealed storage |
Alias : (3beta,12beta)-12-hydroxy-20-((o-beta-d-xylopyranosyl-(1→4)-o-alpha-l-arabinopyranosyl-(1→6)-beta-d-glucopyranosyl)oxy)dammar-24-en-3-yl 2-o-beta-d-glucopyranosyl-beta-d-glucopyranoside
Ginsenoside Ra1 is extracted from roots and rhizomes of Panax ginseng, shows inhibitory effects on protein tyrosine kinase.
Weight | Price | Stock |
---|---|---|
10mg | 362.80$ | In Stock |
20mg | 676.80$ | In Stock |
50mg | 1554.80$ | In Stock |
100mg | 2762.80$ | In Stock |
>300mg | Get quote | In Stock |
Leave message How to purchase?
IC50 Value & Target:
In Vitro: Ra1 and Ro showed significant inhibitory effects on PTK activation induced by H/R. Dose-response experiments revealed that ginsenoside-Rb1 was the most active compound and it completely blocked PTK activation at a wide range of concentrations. Most protopanaxadiol-type ginsenosides and some protopanaxatriol type saponins also showed significant effects on PTK activation.[1].
In Vivo: Have no relevant experimental datas.
M.Wt | 1211.38 |
---|---|
Formula | C58H98O26 |
CAS No. | 83459-41-0 |
Solvent & Solubility | 10 mM in DMSO |
Storage | 2-8ºC & Sealed storage |
Alias : Chikusetsusaponin 5; Chikusetsusaponin V; Polysciasaponin P3; (3beta)-28-(beta-d-glucopyranosyloxy)-28-oxoolean-12-en-3-yl 2-o-beta-d-glucopyranosyl-beta-d-glucopyranosiduronic acid
Ginsenoside Ro, the predominant ginsenoside in the rhizome, is reported to have anti-inflammtory, anti-hepatitic activities, and showed inhibitory activity against 5αR with IC(50) value of 259.4 μm.
Weight | Price | Stock |
---|---|---|
20mg | 160.80$ | In Stock |
50mg | 375.80$ | In Stock |
100mg | 705.80$ | In Stock |
>500mg | Get quote | In Stock |
Leave message How to purchase?
IC50 Value & Target: 259.4 μm (for 5α-reductase )
In Vitro: Ginsenoside Ro exhibited suppressive activities on reactive oxygen species and matrix metalloproteinase-2 elevation in UV-B-irradiated fibroblasts. Ginsenoside Ro could overcome the reduction of the total glutathione contents in UV-B-irradiated fibroblasts. In IL-1β-induced rat chondrocytes, ginsenoside Ro exerted anti-apoptosis and anti-inflammation. Ro could improve IL-1β-induced chondrocytes viability. Ginsenoside Ro could suppress IL-1β-induced apoptosis by inhibiting levels of Bax and Bad, decreasing p53 phosphorylation and promoting the expression of Bcl-xL and PCNA. Ginsenoside Ro inhibited caspase 3 activity. IL-1β-induced inflammation and matrix degration were also alleviated by Ginsenoside Ro with down-regulating the expression of MMP 3, MMP 9 and COX-2. Moreover, ginsenoside Ro inhibited NF-κB p65 phosphorylation induced by IL-1β [2].
In Vivo: Topical administration of ginsenoside Ro (0.2 mg/mouse) to shaved skin inhibited hair re-growth suppression after shaving in the testosterone-treated C57BL/6 mice. Ginsenoside Ro showed inhibitory activity against 5αR with IC(50) value of 259.4 μm [3].
M.Wt | 957.11 |
---|---|
Formula | C48H76O19 |
CAS No. | 34367-04-9 |
Solvent & Solubility | 10 mM in DMSO |
Storage | 2-8ºC & Sealed storage |